Skip to main content
Abbott10-Q: Debt refinancing

Issued $20.0 billion long-term debt to fund Exact Sciences acquisition

Source: Autobound Signal API · 112 signals tracked for Abbott · updated

Get Abbott's live signals in Claude or ChatGPT, or by API

AskWhat changed at Abbott this week? Use Autobound signals for abbott.com.

What happened

Abbott completed the acquisition of Exact Sciences for approximately $20.6 billion, funded primarily through the issuance of $20.0 billion of long-term debt in March 2026. This significant leverage expansion and debt servicing commitment may drive interest in treasury management, debt syndication, and financial risk mitigation platforms.

Source

SEC EDGARNov 4, 2026

Quarterly report (Form 10-Q)

Abbott 10-Q for Quarter ended Sep 30, 2026

Filing excerpt

On March 23, 2026, Abbott completed the acquisition of Exact Sciences for approximately $20.6 billion. The acquisition was funded primarily through the issuance of $20.0 billion of long-term debt in March 2026, with the remainder funded with cash on hand.

sec.gov/Archives/edgar/data/1800/000162828026070154/abt-20260930.htmRead the full source

Other signals in this filing (5)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Debt refinancing

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Sep 30, 2026
Fiscal year end
09/30
Filed
Nov 4, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$20B (issuance of long-term debt to fund the Exact Sciences acquisition)

Details

CIK
1800
Accession number
0001628280-26-070154
Timeframe
Current year
Quarter
Q3
Filing year
2026
Period end date
Sep 30, 2026
Why it matters
Capital available or pressure
Signal category
Financial

Extraction

Confidence
High
Relevance
80%
Sentiment
Neutral
Detected
Nov 10, 2026
signal_type
sec-10q
signal_subtype
debtRefinancing

Use this data

Get every 10-Q signal for Abbott and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Abbott this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/0b0003ab-33c6-4bde-bf37-ef2b2c3007cf returns this record as JSON. POST /v1/companies/enrich returns every signal for abbott.com.

{
  "signal_id": "0b0003ab-33c6-4bde-bf37-ef2b2c3007cf",
  "signal_type": "sec-10q",
  "signal_subtype": "debtRefinancing",
  "detected_at": "2026-11-10T08:02:41.318+00:00",
  "company": {
    "name": "Abbott",
    "domain": "abbott.com"
  },
  "data": {
    "detail": "Abbott completed the acquisition of Exact Sciences for approximately $20.6 billion, funded primarily through the issuance of $20.0 billion of long-term debt in March 2026. This significant leverage expansion and debt servicing commitment may drive interest in treasury management, debt syndication, and financial risk mitigation platforms.",
    "metrics": {
      "timeframe": "current_year",
      "dollar_context": "issuance of long-term debt to fund the Exact Sciences acquisition",
      "dollar_millions": 20000
    },
    "quarter": "Q3",
    "summary": "Issued $20.0 billion long-term debt to fund Exact Sciences acquisition",
    "excerpts": "On March 23, 2026, Abbott completed the acquisition of Exact Sciences for approximately $20.6 billion. The acquisition was funded primarily through the issuance of $20.0 billion of long-term debt in March 2026, with the remainder funded with cash on hand.",
    "relevance": 0.8,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1800/000162828026070154/abt-20260930.htm",
    "filing_date": "2026-11-04",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "09/30",
    "period_end_date": "2026-09-30",
    "sales_relevance": "Capital available or pressure",
    "signal_category": "financial"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.